In this session, Dr. Reichstein, Dr. Schefler, Dr. Hovland, and Dr. Walter will be discussing "Standards of Care for Uveal Melanoma, are there any?"

Topics addressed include:
- NCCN/TNM Staging & guidelines

-Types of Plaque/Proton Beam Treatment

-Transpupillary Thermotherapy (TTT) alone (and why we shouldn't do it)


Dr. David Reichstein, an ocular oncologist, who studied at the renowned Wills Eye Hospital here from Tennessee Retina.

Dr. Amy Schefler, ocular oncologist and renowned eye cancer researcher from Houston Retina, joining us virtually.

Dr. Peter Hovland, who specializes in vitreoretinal disease & surgery, and ophthalmology, here from Colorado Retina.

Dr. Scott Walter, a practicing ophthalmologist in Hartford, Connecticut and is affiliated with Hartford Hospital.

Visit ocularmelanoma.org for more information! This video is part of a series of "Frank Talks on OM".

The 3rd annual Eye Am Not Alone (EANA) Patient Retreat was held Friday, November 1st through Sunday, November 3rd at the Kimmel Cancer Center at Jefferson University Hospital in Philadelphia, PA.

The retreat combined expert medical information with the 'softer side' of battling OM: understanding genetic testing, learning how to navigate insurance, etc. along with plenty of interaction with other patients and OM experts from around the country. Targeted at patients, their families and friends, the retreat mirrored OMF's ground-breaking 2010 conference at the Dana-Farber Cancer Center and its follow-up in Washington, DC in March 2012.

Speakers at the 2013 retreat included: Takami Sato MD, PhD, David Eschelman MD, Carin Gonsalves, MD, Carol Shields, MD, OMF Medical Director Peter Hovland, MD, PhD and OMF Scientific Advisory Board member Colleen Cebulla, MD.

Michelle Martin’s tumor was tiny … about the size of half of a pea, but it was in the back of her eye. She had a cancer called ocular melanoma. But now, cutting-edge instruments are making all the difference in diagnosis and treatment.

Dr. Marcus Butler, of Princess Margaret Cancer Centre, Toronto, Ontario, Canada and Dr. Omid Hamid, of The Angeles Clinic and Research Institute, Los Angeles, California, U.S. discuss current and emerging therapies and practices for treatment of ocular or uveal melanoma.

Dr. Richard Carvajal of Memorial Sloan Kettering Cancer Center speaks on the future of targeted therapy, immunotherapy, and clinical trials for ocular and mucosal melanomas at the 2013 Melanoma Education Symposium hosted by The Angeles Clinic Foundation and AIM at Melanoma